Cargando…
Tenecteplase in Ischemic Stroke: Challenge and Opportunity
PURPOSE OF REVIEW: Intravenous thrombolysis is the first-line therapy for ischemic stroke, and alteplase has been used as an intravenous thrombolysis drug for over 20 years. However, considering its low rate of recanalization and risk of intracerebral hemorrhage, alteplase may not be the optimal thr...
Autores principales: | Li, Guangshuo, Wang, Chuanying, Wang, Shang, Xiong, Yunyun, Zhao, Xingquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109727/ https://www.ncbi.nlm.nih.gov/pubmed/35586365 http://dx.doi.org/10.2147/NDT.S360967 |
Ejemplares similares
-
Clinical Significance and Dynamic Change of Coagulation Parameters in
Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022) -
Clinical Significance of Stress Hyperglycemic Ratio and Glycemic Gap in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022) -
Association Between Neutrophil-to-Lymphocyte Ratio/Lymphocyte-to-Monocyte Ratio and In-Hospital Clinical Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022) -
Intravenous thrombolysis for acute ischemic stroke during two COVID-19 outbreaks in China: Wuhan pandemic and Beijing pandemic
por: Li, Guangshuo, et al.
Publicado: (2023) -
In-hospital clinical outcomes in diffusion weighted imaging-negative stroke treated with intravenous thrombolysis
por: Li, Guangshuo, et al.
Publicado: (2022)